Lecture 6 - Schizophrenia Spectrum Disorder Flashcards
Positive Schiz symptoms
Delusions = false beliefs
Hallucinations = sensory perception w/ no basis
Disorganized speech
Grossly disorganized/catatonic behavior
Negative Schiz symptoms
Blunted affect
Alogia = cant speak
Avolition
Anhedonia = trouble w/ pleasure
Asociality
DSM - 5 Schiz Diagnosis
2> symptoms (pos/neg/cognitive) for atleast 1 month
> 1 symptoms must be Delusions, Hallucinations, disorganized speech
1> areas of function (work, relationships, self care) marked below prev lvl
Duration lasting at least 6 month, at least 1 month of symptoms
** Doesn’t meet criteria for Schizoaffective or modo disorders, substance/general medical condition, or hx of autism spectrum disorder **
Mesolimbic pathophysiology
Excess DA = Positive sx
txm w/ DA antagonist = relief of positive sx
Mesocotical pathophysiology
Low DA = negative n cognitive sx
txm w/ DA antagonist = worsen neg symptoms
Nigrostriatal pathophysiology
Normal DA = no dysfunction
txm w/ DA antagonist = extrapyramidal sx
Tuberoinfundibular pathophysiology
Normal DA = no dysfunction
txm w/ DA antagonist = hyperprolactinemia
Schiz Txm approach
acute phase = 1-2 wks ( dec symptoms, develop plan)
Stabilization = 3-4 wks ( dec symptoms, optimize regimen)
Maintenance = Life long, inc QoL, Functioning, prevent relapse
1st Gen anti psych indications
Acute agitation n delirium usually what used for
Which FGA used for Tourettes syndrome
Haloperidol
pimozide
Which FDA used in N/V
Chlorpromazine
Perphenazine
Prochlorperazine
Which FGA used for Intractable hiccups
Chlorpromazine
First Gen Antipsychotic MoA
1st = blockade of DA2 receptors in mesolimbic area and mesocortical area of brain
FGA Dosing
start low, titrate to lowest effective dose
usually see effects within few days, full benefit 4-6wk
D/c should be slow taper over several weeks to months
FGA acute txm
inc dose until behavior improves or SE
IM/Iv formulations are 2-4x more potent and should only be used in acute setting
Extrapyramidal symptoms
most common w/ FGA, onset within 2-3wk of starting txm or dose inc
Pseudoparkinonism = symptoms of Parkinson’s disease (rest tremor, shuffle, etc)
Akathisia = unable to stay still
Acute dystonia = spastic muscle movement w/in 24-96hr dose change
How to help treat Pseudoparkinonism symptoms
dose dc or add anticholinergic (benzotropine)
How to help treat Akathisia symptoms
dose dc or switch antipsychotic, add propranolol or anticholinergic
How to help treat Acute dystonia symptoms
Mod/severe = IV/IM benztropine 1-2mg or diphenhydramine 25-50mg
Mild = PO benzotropine 1-2mg QD or BID
How to help treat Acute dystonia symptoms
Mod/severe = IV/IM benztropine 1-2mg or diphenhydramine 25-50mg
Mild = PO benzotropine 1-2mg QD or BID
Tardive Dyskinesia info
Myoclonic jerks, tics…often involving face/mouth
usually long term antipsychotic use and potentially irreversible
Risk factors = Long term, high dose/potency FGA, older age n females
Monitoring = AIMS or DISCUS (Q6M FGA, Q12M SGA)
Tardive Dyskinesia TXM
D/c antipsychotic and switch to one with lower risk
VMAT2 Inhibitor
VMAT2 inhibitors MOA
reversible inhibition of VMAT2 which is transporter that packages DA into presynaptic vesicles in prep for release into synaptic cleft
Deutetrabenazine (Austere)
VMAT 2 inhib
Warning = QTc prolongation, Parkinsonism, Depression or suicidality
ADE = Somnolence, Fatigue, Diarrhea
DI = Strong 2D6 = reduce dose, other QTc prolong drugs
Counseling = Take with food